BC
NBIX icon

Brookfield Corp’s Neurocrine Biosciences NBIX Stock Holding History

Brookfield Corp’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-66,243
Closed -$6.21M – 686
2022
Q1 		$6.21M Buy
+66,243
New +$6.21M 0.02% 219